Torbjörn Mattias Koivisto
Director/Board Member at XSPRAY PHARMA AB
Net worth: 23 624 $ as of 2024-03-30
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Per Andersson | M | 57 | 18 years | |
| Wenche Nelly A. Rolfsen Sandsborg | M | 72 |
Cinclus Pharma Holding AB
 Cinclus Pharma Holding AB BiotechnologyHealth Technology Cinclus Pharma Holding AB is a Swedish pharmaceutical company that focuses on developing clinical stage drug candidates for gastric acid related diseases. The company's drug candidate, linaprazan glurate, takes a new approach to provide improved management of GERD. Gastroesophageal reflux disease, or acid reflux, is a condition in which the content of the stomach regurgitates into the esophagus. The company was founded by pioneers in GERD treatment with extensive experience from Astra and Astra Zeneca. Christer Ahlberg has been the CEO of the company since 2021. | 8 years |
| Christine Lind | F | 50 | 5 years | |
| Kerstin Hasselgren | F | 63 | 5 years | |
| Stig Lennart Hansson | M | 68 |
Cinclus Pharma Holding AB
Cinclus Pharma Holding AB BiotechnologyHealth Technology Cinclus Pharma Holding AB is a Swedish pharmaceutical company that focuses on developing clinical stage drug candidates for gastric acid related diseases. The company's drug candidate, linaprazan glurate, takes a new approach to provide improved management of GERD. Gastroesophageal reflux disease, or acid reflux, is a condition in which the content of the stomach regurgitates into the esophagus. The company was founded by pioneers in GERD treatment with extensive experience from Astra and Astra Zeneca. Christer Ahlberg has been the CEO of the company since 2021. | - |
| Edward Jordan | M | 55 | 1 years | |
| Anna-Karin Ekberg | F | - | 2 years | |
| Robert Molander | M | 59 | 2 years | |
| Michael af Winklerfelt | M | 52 | - | |
| Mark Beveridge | M | 46 | 9 years | |
| Jenni Björnulfson | F | 53 |
Cinclus Pharma Holding AB
Cinclus Pharma Holding AB BiotechnologyHealth Technology Cinclus Pharma Holding AB is a Swedish pharmaceutical company that focuses on developing clinical stage drug candidates for gastric acid related diseases. The company's drug candidate, linaprazan glurate, takes a new approach to provide improved management of GERD. Gastroesophageal reflux disease, or acid reflux, is a condition in which the content of the stomach regurgitates into the esophagus. The company was founded by pioneers in GERD treatment with extensive experience from Astra and Astra Zeneca. Christer Ahlberg has been the CEO of the company since 2021. | - |
| Christer Ahlberg | M | 53 |
Cinclus Pharma Holding AB
Cinclus Pharma Holding AB BiotechnologyHealth Technology Cinclus Pharma Holding AB is a Swedish pharmaceutical company that focuses on developing clinical stage drug candidates for gastric acid related diseases. The company's drug candidate, linaprazan glurate, takes a new approach to provide improved management of GERD. Gastroesophageal reflux disease, or acid reflux, is a condition in which the content of the stomach regurgitates into the esophagus. The company was founded by pioneers in GERD treatment with extensive experience from Astra and Astra Zeneca. Christer Ahlberg has been the CEO of the company since 2021. | 3 years |
| Anders Lennart Bladh | M | 66 | 3 years | |
| Andreas Konar | M | 75 | 14 years | |
| Charlotta Liljebris | M | 60 | 6 years | |
| Sven Håkan Björklund | M | 68 |
Kibacq AB
| - |
| Anders Olof Adolf Ekblom | M | 70 | 2 years | |
| Carl-Johan Spak | M | 68 | 9 years | |
| Maris Gunars Hartmanis | M | 71 | 9 years | |
| Thomas Walz | M | - | 2 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Thomas Lennart Eklund | M | 57 | 4 years | |
| Mats Gunnar Pettersson | M | 78 | 6 years | |
| Mattias Klintemar | M | 57 | - | |
| Torbjörn Wärnheim | M | 66 | 7 years | |
| Gunnar Gårdemyr | M | 65 | 3 years | |
| Thomas Bjerregaard Thomsen | M | 54 | 4 years | |
| Geert Cauwenbergh | M | 70 | 7 years | |
| Christina Malmberg Hägerstrand | F | - | - | |
| Ernst Åke Bertil Karlmark | M | 86 | 6 years | |
| Jeff Vernimb | M | 61 | 2 years | |
| Martin Ingman | M | 62 | 9 years | |
| Bengt Åke Ingemar Aldén | M | 81 | - | |
| Peter Michael Rothschild | M | 74 | - | |
| Lena Pereswetoff Morath | M | 64 | - | |
| Magnus Persson | M | 60 | - | |
| Marie Scherlund | M | 58 | - | |
| George Aitken-Davies | M | 46 | 2 years | |
| Ingela Berglund | F | - | - | |
| Anna Yvonne Monica Malm Bernsten | F | 63 | 1 years | |
| Sarah Hellerfelt | F | 42 | 2 years | |
| Fredrik Netzel | M | 55 | 8 years | |
| Sara Catherine Brandt | F | 61 | 2 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| Sweden | 42 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Torbjörn Mattias Koivisto
- Personal Network
